Seeking Alpha

Roche (RHHBY.OB) has, for the first time, agreed to let scientists examine hundreds of pages of...

Roche (RHHBY.OB) has, for the first time, agreed to let scientists examine hundreds of pages of clinical trial data for Tamiflu. Some have suggested the flu treatment — which brought in $3.4B in revenue during the Swine Flu panic of 2009 — contributes to suicidal thoughts, a claim Roche strongly denies. The data will be made available after it is edited "to ensure patient confidentiality." 
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|